Director of Hyderabad-based Centre for Cellular & Molecular Biology, Dr Rakesh Mishra said closer surveillance is needed to understand the spread of Covid-19 variants properly.
New variant of Sars-Cov-2 not impediment to vaccine development, says CCMB hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
NEW DELHI: Bhabha Atomic Research Centre (BARC)-developed eye cancer therapy has been successfully used for the first time for the treatment of patients with ocular tumours in AIIMS-Delhi and the results of using Ruthenium 106 plaque for treatment of a patient with choroidal hemangioma (benign tumour in blood vessels) have been found to be satisfactory.
Union minister of state for atomic energy Jitendra Singh, who facilitated the collaboration between the Department of Atomic Energy (DAE) and Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, Delhi, informed about the breakthrough and lauded the BARC for developing the “simple and cost-effective therapy” for eye cancer patients.
New Variant Of Coronavirus 71% More Transmittable by Colleen Fleiss on December 29, 2020 at 11:07 PM
The coronavirus s new variant is believed to be 71% more transmittable than the other variants, said the Hyderabad-based Centre for Cellular and Molecular Biology (CCMB).
CCMB has underlined the importance of launching extensive genome surveillance of the virus to assess the extent of the new virus s spread. We should also keep an eye on other variants that might emerge independently, as India houses the second largest population infected with this virus, at present, CCMB Director, Dr Rakesh Mishra said.
‘India has confirmed six new cases of the new mutant coronavirus strain.’
Express News Service
HYDERABAD: India has the world s second largest number of Covid-19 cases but when it comes to genome sequencing of the novel coronavirus, the country s performance is shocking.
Of the more than 1.01 crore cases reported in India, only 4,238 novel coronavirus samples or just about 0.04 percent of all cases have been sequenced till now, as per the database of novel coronavirus genomes sequenced worldwide available with the GISAID Initiative.
Even this number is not evenly spread across the country s geography. While Andhra Pradesh and Tamil Nadu have recorded third and fourth highest number of Covid-19 cases, a meager 3 and 36 virus samples have been sequenced from these states.